Braun Stacey Associates’s Sanofi SNY Stock Holding History

Braun Stacey Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,700	Closed	-$309K	–	154
2016 Q1	$309K	Hold	7,700	–	–	0.02%	144
2015 Q4	$328K	Hold	7,700	–	–	0.02%	133
2015 Q3	$366K	Hold	7,700	–	–	0.02%	129
2015 Q2	$381K	Hold	7,700	–	–	0.02%	248
2015 Q1	$381K	Buy	7,700 +1,000	+15%	+$47.8K	0.02%	128
2014 Q4	$306K	Hold	6,700	–	–	0.02%	141
2014 Q3	$378K	Hold	6,700	–	–	0.02%	124
2014 Q2	$356K	Buy	6,700 +2,600	+63%	+$138K	0.02%	127
2014 Q1	$214K	Buy	+4,100	New	+$208K	0.01%	149

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Braun Stacey Associates's SNY Position: Q2 2016 in Review

Braun Stacey Associates sold out of Sanofi (SNY) in Q2 2016, closing a stake of 7,700 shares — an estimated $309K sold.

Braun Stacey Associates first reported a position in SNY in Q1 2014 and held it in 9 quarters. The position peaked at $381K in Q2 2015. 449 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

Braun Stacey Associates reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
Braun Stacey Associates sold 7,700 Sanofi shares in Q2 2016, an estimated $309K.
Braun Stacey Associates first reported a position in Sanofi in Q1 2014 and held it in 9 quarters.
Braun Stacey Associates's Sanofi position peaked at $381K in Q2 2015.
449 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on Braun Stacey Associates's 13F filing for Q2 2016, filed 19 Aug 2016.